Navigation Links
Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry

MINNEAPOLIS, Feb. 29 /PRNewswire/ -- Vallon Holdings, LLC, a Minneapolis-based privately-held holdings company, has launched Vallon LifeScience, a new professional services subsidiary providing experienced interim and contract resources to Minneapolis-St. Paul life science companies.

"Vallon LifeScience is a breakthrough in one of the key problems facing life science companies today," states Paula J. Norbom, President and Founder of Vallon LifeScience. " to rapidly find the best and most experienced industry talent to continue driving your business forward."

Minneapolis-St. Paul is a prolific market for medtech, biotech, pharmaceutical and healthcare companies. Vallon LifeScience and their deep network of talent, is uniquely equipped to meet the increasing demands for highly specialized interim and contract professionals. Doug Ruth, CEO of Vallon Holdings, LLC, states, "Our new LifeScience subsidiary will give companies immediate access to talented life science resources that will help them meet operational, product development, commercialization and strategic challenges."

For an industry that features distinct challenges in getting products to market, Vallon LifeScience is offering a remarkable solution without the same hassles of working with a typical consulting or staffing firm. "We quickly provide our clients with the best-matched professional to grow their businesses," states Norbom. "When you know the right people, it's that simple."

In addition to the launch, the firm unveiled a new web site for Vallon LifeSciences which can be viewed at

About Vallon Holdings, LLC.

Vallon Holdings, LLC is a privately-held holdings company with two subsidiaries: Vallon LifeScience, LLC that provides contract resources for the life science industry and Vallon LLC that provides companies with experienced executives for project and interim assignments. Our talent includes CEO's, COO's, and General Managers as well as executives focused on Performance Management activities such as Sales and Marketing, Global Supply Chain, Lean Manufacturing, Six Sigma and PMO Leadership. For more information on Vallon visit

SOURCE Vallon Holdings, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NightHawk Radiology Holdings, Inc. Announces Board Member Departure
2. NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008
3. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
4. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
5. NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance
6. Berkery Noyes Represented The Riverside Company on the Sale of HCPro Holdings, Inc. to Halyard Capital, LLC
7. NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call
8. MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc.
9. MBF Healthcare Acquisition Corp. Announces Signing of Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc.
10. NightHawk Radiology Holdings, Inc. Announces Date for Fourth Quarter and Full-Year 2007 Earnings Conference Call
11. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center ... and is the only hospital in the region providing what is known as ... transcatheter pacing patients were revealed recently at a medical conference and published in ...
(Date:12/1/2015)... MD (PRWEB) , ... December 01, 2015 , ... ... salmon identification tests to continue the expansion of the company’s growing product line ... – for Chinook (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... Health Center of Excellence (BHCOE) today announced that the organization has awarded Education ... San Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... for Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or ... anticipated results, once a deal is signed. This quick-read guidance suggests that ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... During the recent 2015 Transcatheter Cardiovascular ... CA , Medinol Ltd. continued to introduce ... a satellite symposium, "The BioNIR eDES: The Role ... a renowned physician panel discussed the key attributes ... Stent System and the Medinol eDES Coronary Stent ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
Breaking Medicine Technology: